Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Impact of hepatocyte growth factor on skeletal myoblast transplantation late after myocardial infarction.

O'Blenes SB, Li AW, Bowen C, Debay D, Althobaiti M, Clarke J.

Drug Target Insights. 2013 May 6;7:9-17. doi: 10.4137/DTI.S11802. Print 2013.

2.

Engraftment is optimal when myoblasts are transplanted early: the role of hepatocyte growth factor.

O'Blenes SB, Li AW, Chen R, Arora RC, Horackova M.

Ann Thorac Surg. 2010 Mar;89(3):829-35. doi: 10.1016/j.athoracsur.2009.12.007.

PMID:
20172138
3.

Stem cell therapy enhances electrical viability in myocardial infarction.

Mills WR, Mal N, Kiedrowski MJ, Unger R, Forudi F, Popovic ZB, Penn MS, Laurita KR.

J Mol Cell Cardiol. 2007 Feb;42(2):304-14. Epub 2006 Oct 27.

PMID:
17070540
4.

Electrophysiological consequence of skeletal myoblast transplantation in normal and infarcted canine myocardium.

Fouts K, Fernandes B, Mal N, Liu J, Laurita KR.

Heart Rhythm. 2006 Apr;3(4):452-61.

PMID:
16567294
6.

Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy.

Askari A, Unzek S, Goldman CK, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS.

J Am Coll Cardiol. 2004 May 19;43(10):1908-14.

7.
8.

hHGF overexpression in myoblast sheets enhances their angiogenic potential in rat chronic heart failure.

Siltanen A, Kitabayashi K, Lakkisto P, Mäkelä J, Pätilä T, Ono M, Tikkanen I, Sawa Y, Kankuri E, Harjula A.

PLoS One. 2011 Apr 26;6(4):e19161. doi: 10.1371/journal.pone.0019161.

9.

Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.

Li Y, Takemura G, Kosai K, Yuge K, Nagano S, Esaki M, Goto K, Takahashi T, Hayakawa K, Koda M, Kawase Y, Maruyama R, Okada H, Minatoguchi S, Mizuguchi H, Fujiwara T, Fujiwara H.

Circulation. 2003 May 20;107(19):2499-506. Epub 2003 Apr 14.

10.

Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure.

Jayasankar V, Woo YJ, Pirolli TJ, Bish LT, Berry MF, Burdick J, Gardner TJ, Sweeney HL.

J Card Surg. 2005 Jan-Feb;20(1):93-101.

PMID:
15673421
11.

Cardiovascular magnetic resonance imaging in delivering and evaluating the efficacy of hepatocyte growth factor gene in chronic infarct scar.

Saeed M, Saloner D, Do L, Wilson M, Martin A.

Cardiovasc Revasc Med. 2011 Mar-Apr;12(2):111-22. doi: 10.1016/j.carrev.2010.05.003. Epub 2010 Oct 20.

12.

Circulating levels of hepatocyte growth factor and left ventricular remodelling after acute myocardial infarction (from the REVE-2 study).

Lamblin N, Bauters A, Fertin M, de Groote P, Pinet F, Bauters C.

Eur J Heart Fail. 2011 Dec;13(12):1314-22. doi: 10.1093/eurjhf/hfr137. Epub 2011 Oct 13.

13.

Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix.

Zhang G, Hu Q, Braunlin EA, Suggs LJ, Zhang J.

Tissue Eng Part A. 2008 Jun;14(6):1025-36. doi: 10.1089/ten.tea.2007.0289.

PMID:
18476809
14.
16.

Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs.

He KL, Yi GH, Sherman W, Zhou H, Zhang GP, Gu A, Kao R, Haimes HB, Harvey J, Roos E, White D, Taylor DA, Wang J, Burkhoff D.

J Heart Lung Transplant. 2005 Nov;24(11):1940-9. Epub 2005 Aug 24.

PMID:
16297802
17.

Early treatment with hepatocyte growth factor improves cardiac function in experimental heart failure induced by myocardial infarction.

Jin H, Yang R, Li W, Ogasawara AK, Schwall R, Eberhard DA, Zheng Z, Kahn D, Paoni NF.

J Pharmacol Exp Ther. 2003 Feb;304(2):654-60.

18.

Possible mechanism by which renal sympathetic denervation improves left ventricular remodelling after myocardial infarction.

Zheng XX, Li XY, Lyu YN, He YY, Wan WG, Zhu HL, Jiang XJ.

Exp Physiol. 2016 Feb;101(2):260-71. doi: 10.1113/EP085302. Epub 2015 Dec 16.

PMID:
26556551
19.

Transplanted human cord blood-derived unrestricted somatic stem cells improve left-ventricular function and prevent left-ventricular dilation and scar formation after acute myocardial infarction.

Ghodsizad A, Niehaus M, Kögler G, Martin U, Wernet P, Bara C, Khaladj N, Loos A, Makoui M, Thiele J, Mengel M, Karck M, Klein HM, Haverich A, Ruhparwar A.

Heart. 2009 Jan;95(1):27-35. doi: 10.1136/hrt.2007.139329. Epub 2008 Jun 2.

PMID:
18519547
20.

Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.

Yang ZJ, Ma DC, Wang W, Xu SL, Zhang YQ, Chen B, Zhou F, Zhu TB, Wang LS, Xu ZQ, Zhang FM, Cao KJ, Ma WZ.

Gene Ther. 2006 Nov;13(22):1564-8. Epub 2006 Jun 29.

PMID:
16810195

Supplemental Content

Support Center